Genetic knockout of Cbl-b markedly enhances the cytotoxic efficacy of NK cells and increases the production of IFN-γ and the release of perforin, thereby augmenting their tumor cell-killing efficacy [12]. The gene discussed is CBLB; the disease is neoplasm.